CytoDyn (CYDY) Common Equity (2011 - 2026)
CytoDyn (CYDY) recorded Common Equity of -$109.72 million in fiscal Q4 2026 (quarter ended May 31, 2026), compared with -$96.04 million a year earlier.
Powered by 
Analysis
CytoDyn (CYDY) Common Equity (2011 - 2026) Analysis & Trends
Starting with fiscal Q4 2011, CytoDyn's Common Equity history includes 61 quarters.
- Across earlier fiscal years, Common Equity came in at -$96.04 million in FY2025, -$116.76 million in FY2024, -$109.5 million in FY2023 and -$94.4 million in FY2022.
- Quarterly Common Equity has ranged from -$119.75 million in fiscal Q2 2026 to -$12.7 million in fiscal Q2 2022 over the past five years.
- Per Business Quant, the preceding three fiscal quarters came in at -$104.29 million (Q3 2026), -$119.75 million (Q2 2026) and -$99.5 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | CytoDyn | 288.44 Mn | 288.44 Mn | - | -109.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -109.72 Mn |
| Feb 28, 2026 | -104.29 Mn |
| Nov 30, 2025 | -119.75 Mn |
| Aug 31, 2025 | -99.50 Mn |
| May 31, 2025 | -96.04 Mn |
| Feb 28, 2025 | -92.98 Mn |
| Nov 30, 2024 | -89.39 Mn |
| Aug 31, 2024 | -85.21 Mn |
| May 31, 2024 | -116.76 Mn |
| Feb 29, 2024 | -119.38 Mn |
| Nov 30, 2023 | -114.38 Mn |
| Aug 31, 2023 | -116.89 Mn |
| May 31, 2023 | -109.50 Mn |
| Feb 28, 2023 | -107.01 Mn |
| Nov 30, 2022 | -115.97 Mn |
| Aug 31, 2022 | -94.31 Mn |
| May 31, 2022 | -94.40 Mn |
| Feb 28, 2022 | -22.46 Mn |
| Nov 30, 2021 | -12.70 Mn |
| Aug 31, 2021 | -25.19 Mn |
API Access
CytoDyn Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();